Centers for Disease Control and Prevention

Imprimis releases low-cost Daraprim alternative

Monday, October 26, 2015

Imprimis Pharmaceuticals, a specialty pharmaceutical company focused on the development and commercialization of proprietary compounded drug therapies, has made a customizable, compounded formulation of pyrimethamine and leucovorin available for physicians to consider prescribing for their patients as a low-cost alternative to Daraprim.

[Read More]

CDC, Edico Genome partner on DRAGEN Hardware Platform

Monday, October 12, 2015

The Centers for Disease Control and Prevention, through the National Center for Emerging and Zoonotic Infectious Diseases, Office of Advanced Molecular Detection (OAMD), and Edico Genome have entered into a research collaboration to evaluate the performance of Edico Genome’s DRAGEN hardware platform. The goal of this research collaboration is to evaluate the utility of the Edico Genome DRAGEN platform for public health and infectious disease applications. This collaboration also will focus on co-developing the databases, configurations and parameters to optimize the hardware platform for microbial applications.

[Read More]

U.S., Canada partner for research hubs in LMICs

Friday, October 9, 2015

The NIH and other U.S. and Canadian partners are investing $20.9 million dollars over five years to establish seven regional research and training centers in low- and middle-income countries (LMICs). The Global Environmental and Occupational Health (GEOHealth) Hubs will consist of multidisciplinary groups of researchers and partner organizations collaborating on common research and training topics that address environmental and/or occupational health issues.

[Read More]

PPD awarded Army, BARDA research contracts

Thursday, October 8, 2015

has been awarded two separate U.S. government contracts to improve health outcomes for armed forces service members and to help test the effectiveness of the nation’s stockpile of avian influenza vaccine to safeguard the public.

[Read More]

Nanomedical Diagnostics launches

Monday, September 21, 2015

Nanomed co-founders Ross Bundy and Dr. Brett Goldsmith have launched Nanomedical Diagnostics, a San Diego-based biotech company developing and commercializing bioelectronics for use in research and diagnostics. Nanomed’s first product, AGILE Research, a label-free, quantitative, low-cost biosensor for small molecule and protein analysis, is entering beta testing this fall and planned for commercial release in early 2016.

[Read More]

NIH launches human RSV study

Monday, August 31, 2015

A new study will expose healthy adult volunteers to respiratory syncytial virus (RSV), a virus that causes cold-like symptoms in adults. Better understanding of how adults develop RSV infection and immune system responses to infection will assist researchers in developing and testing future antivirals and vaccines to combat the virus. The research is being conducted by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

[Read More]

Thermo Fisher Scientific, CDC partner to accelerate global microbial identification

Friday, July 17, 2015

Through a partnership with the Special Bacteriology Reference Laboratory at the Centers for Disease Control and Prevention (CDC), Thermo Fisher Scientific has developed an advanced software solution that enables global public health laboratories to directly access the CDC’s MicrobeNet online virtual reference lab database. Now, researchers can more quickly identify microbial pathogens potentially at the root of global outbreaks without needing to refer to multiple databases by instead utilizing one curated by subject matter experts in the field.

[Read More]